Form 4: HealthStream SVP Kevin O'Hara Acquires Restricted Share Units
SEC Form 4
HealthStream's Senior Vice President, Kevin O'Hara, reports the acquisition of restricted share units (RSUs) based on performance criteria and continued service.
Summary
- Kevin O'Hara, Senior Vice President at HealthStream Inc., filed a Form 4 disclosing changes in beneficial ownership.
- On August 23, 2024, O'Hara acquired 6,100 Restricted Share Units (RSUs).
- These RSUs represent the contingent right to receive one share of common stock upon vesting.
- Vesting is contingent upon continued service and the achievement of certain performance criteria set annually by the Compensation Committee.
- O'Hara directly owns 9,527 shares of HealthStream common stock following the reported transaction.
- The vesting schedule for the RSUs is as follows: up to 10% on February 23, 2025; up to 15% on February 23, 2026; up to 20% on February 23, 2027; up to 25% on February 23, 2028; and up to 30% on February 23, 2029, based on performance during specific periods.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns management interests with shareholder value. The vesting conditions add a layer of performance-based incentive.
Positives
- The acquisition of RSUs aligns O'Hara's interests with the long-term performance of HealthStream.
- The vesting schedule incentivizes continued service and achievement of performance goals.
Risks
- The vesting of RSUs is contingent upon meeting performance criteria, which introduces uncertainty.
- Failure to meet performance criteria could result in RSUs not vesting.
Future Outlook
The vesting of RSUs is tied to future performance and continued service, indicating an expectation of continued contributions from the executive.
Industry Context
This type of equity compensation is common in the healthcare technology industry to incentivize executives and align their interests with shareholder value.
Comparison to Industry Standards
- Many companies in the healthcare technology sector, such as Cerner (now Oracle Health) and Allscripts, use RSUs as part of their executive compensation packages.
- The vesting schedules and performance criteria are generally aligned with industry best practices to retain talent and drive company performance.
- The specific performance metrics used for vesting are typically confidential but often include revenue growth, profitability, and customer satisfaction targets.
Stakeholder Impact
- Shareholders may view this as a positive sign, aligning executive compensation with company performance.
- Employees may see this as a standard practice for executive compensation.
Key Dates
| Date | Description |
|---|---|
| 08/23/2024 | Date of RSU acquisition |
| 02/23/2025 | First vesting date (up to 10%) |
| 02/23/2026 | Second vesting date (up to 15%) |
| 02/23/2027 | Third vesting date (up to 20%) |
| 02/23/2028 | Fourth vesting date (up to 25%) |
| 02/23/2029 | Final vesting date (up to 30%) |
| 08/27/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.